Establishing an oral anticoagulant monitoring service in a multiethnic developing country

International Journal of Laboratory Hematology

Volumn 30, Issue 6, 2008, Pages 531-535

  Casimire, T ^b   Carter, R ^b   Peters, S ^b   Tweedle, J ^c   Charles, K S ^a  

^a National Blood Transfusion Service   (Trinidad and Tobago)

^b Port of Spain General Hospital   (Trinidad and Tobago)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anticoagulant; Monitoring; Multiethnic

Indexed keywords

ANTICOAGULANT AGENT;

AFRICAN AMERICAN; ARTICLE; BLEEDING; DEVELOPING COUNTRY; ETHNIC GROUP; HEALTH SERVICE; HUMAN; INDIAN; INTERNATIONAL NORMALIZED RATIO; PRIORITY JOURNAL; PROTHROMBIN TIME; TRINIDAD AND TOBAGO;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION; DEVELOPING COUNTRIES; DRUG MONITORING; HEMORRHAGE; HUMANS; PROTHROMBIN TIME; THROMBOEMBOLISM; TRINIDAD AND TOBAGO; WARFARIN;

EID: 55149102642     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00995.x     Document Type: Article

References (16)

1. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A. Hylek E. (2004) The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (Suppl. 3 204s 233s.
2. Baglin T.P., Keeling D.M., Watson H.G British Committee for Standards in Haematology (2006) Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. British Journal of Haematology 132, 277 285.
3. Blann A., Hewitt J., Siddiqui F. Bereford D. (1999) Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0. British Journal of Haematology 107, 207 209.
4. Bond S., Rhodes S., James R., Talor M., Green E.S., Rose P. Emmas C. (2004) Health care costs of treating bleeding and other complications associated with warfarin treatment of atrial fibrillation and venous thromboembolism in the UK. British Journal of Haematology 125 (Suppl. 1 58.
5. British Committee for Standards in Haematology (1990) Guidelines for oral anticoagulation: second edition. Journal of Clinical Pathology 43, 177 183.
6. British Committee for Standards in Haematology (1998) Guidelines on oral anticoagulation. British Journal of Haematology 101, 374 387.
7. Butler A.C. Tait R.C. (1998) Management of oral anticoagulant-induced intracranial haemorrhage. Blood Reviews 12, 35 44.
8. Critchfield G.C. Bennett S.T. (1994) The influence of the reference mean prothrombin time on the international normalized ratio. American Journal of Clinical Pathology 102, 806 811.
9. Dang M.T., Hambleton J. Kayser S.R. (2005) The influence of ethnicity on warfarin dosage requirement. Annals of Pharmacotherapeutics 39, 1008 1012.
10. Gan G.G., The A., Goh K.Y., Chong H.T. Pang K.W. (2003) Racial background is a determinant factor in the maintenance dosage of warfarin. International Journal of Haematology 78, 84 86.
11. Geisen C., Watzka M., Sittinger K., Steffens M., Daugela L., Seifried E., Muller C.R., Wienker T.F. Oldenburg J. (2005) VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thrombosis and Haemostasis 94, 773 779.
12. Lee S.C., Oldenburg J., Chong P.Y., Rost S., Guo J.Y., Yap H.L., Rankin S.C., Khor H.B., Yeo T.C., Ng K.S., Soong R. Goh B.C. (2006) Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clinical Pharmacology and Therapeutics 79, 197 205.
13. Palareti G., Leali N., Coccheri S., Poggi M., Manottti C., D'Angelo A., Pengo V., Erba N., Moia M., Ciavarella N., Devoto G., Berrettini M. Musolesi S. (1996) Bleeding complications of oral anticoagulant treatment - an inception cohort, prospective collaborative study (ISCOAT). Lancet 348, 423 428.
14. Poller L., Wright D. Rowlands M. (1993) Prospective comparative study of computer programs used for management of warfarin. Journal of Clinical Pathology 46, 299 303.
15. Shetty H., Backhouse G., Bentley D. Routledge P. (1992) Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. Thrombosis and Haemostasis 67, 13 15.
16. Wittkowsky A.K. Devine E.B (2004) Frequency and causes of over and underanticoagulation in patients treated with warfarin. Pharmacotherapy 24, 1311 1316.